2nd Quarter - Report

AMERICAN ACADEMY OF NEUROLOGY for AMERICAN ACADEMY OF NEUROLOGY

Firm
Client
Income
—
Expenses
$280,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 460, Patients' Access to Treatments Act H.R. 1098/ S. 2539, Traumatic Brain Injury Reauthorization Act H.R. 1508/ S. 1091, Alzheimers Disease Research Semipostal StampCoverage and appropriate use of telemedicine, VA Epilepsy Centers of Excellence, NIH, SSA medical criteria in evaluating neurological disorders including seizures, Dissemination of safety alerts

LobbyistCovered position, as disclosed
MICHAEL J AMERY —
DEREK CHRISTOPHER BRANDT —
DANEEN P GROOMS —
BRUCE SIGSBEE —

Contacted: Social Security Administration (SSA); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA)

Bills named: H.R. 1508 (113th), S. 1091 (113th), H.R. 460 (113th), S. 2539 (113th), H.R. 1098 (113th)

Medicare/Medicaid MMM

S. 577 / HR 1180, Resident Physician Shortage Reduction Act of 2013: Graduate medical education-residency training S. 755/ H.R. 1838, Enhanced Access to Medicaid Services Act of 2013: Amends title XIX (Medicaid) of the Social Security Act H.R. 1173, Personalize Your Care Act of 2013: Voluntary advance care planning consultation in Medicare H.R. 1201, Training Tomorrow's Doctors Today Act: Graduate medical education-residency trainingH.R. 4106, Saving Lives, Saving Costs Act: Provides safe harbors for practitioners following evidence based guidelines H.R. 4695, Amends title XVIII (Medicare) of the Social Security Act to include in the initial preventive physical examination covered under the Medicare program sleep apnea screening Permanent repeal to the sustainable growth rate (SGR) formula; CMS coverage for oxygen for cluster headaches; Preservation of the in-office ancillary exception to the Stark law, Advocate for reimbursement and use of advance care planning; Challenges developing meaningful quality of life measures, Episode of care document and early detection tools for mild cognitive impairment

LobbyistCovered position, as disclosed
MICHAEL J AMERY —
DEREK CHRISTOPHER BRANDT —
DANEEN P GROOMS —
BRUCE SIGSBEE —

Contacted: Social Security Administration (SSA); SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 1180 (113th), H.R. 1838 (113th), H.R. 1201 (113th), H.R. 1173 (113th), H.R. 4695 (113th), S. 755 (113th), S. 577 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.